Literature DB >> 6342899

Clinical pharmacokinetics of oral contraceptive steroids.

M L Orme, D J Back, A M Breckenridge.   

Abstract

Entities:  

Keywords:  Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Agents--pharmacodynamics; Contraceptive Methods--pharmacodynamics; Ethinyl Estradiol--pharmacodynamics; Ethynodiol Diacetate--pharmacodynamics; Family Planning; Human Milk--analysis; Lactation; Levonorgestrel--pharmacodynamics; Lynestrenol--pharmacodynamics; Maternal Physiology; Mestranol--pharmacodynamics; Metabolic Effects; Norethindrone Acetate; Norethindrone--pharmacodynamics; Norethynodrel--pharmacodynamics; Oral Contraceptives--pharmacodynamics; Physiology; Reproductive Control Agents

Mesh：

Substances：

Year:  1983        PMID： 6342899     DOI： 10.2165/00003088-198308020-00001

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  263 in total

1.  Metabolism of norethynodrel in thrombophlebitic-thromboembolic subjects.

Authors:  R W Handy; D Dominquez; M Poirier; M E Wall; C E Cook; C D Christian; R Bressler
Journal:  Experientia       Date:  1975-04-15

2.  d-Norgestrel concentrations in maternal plasma, milk, and child plasma during administration of oral contraceptives to nursing women.

Authors:  S Nilsson; K G Nygren; E D Johansson
Journal:  Am J Obstet Gynecol       Date:  1977-09-15       Impact factor: 8.661

3.  Plasma levels of d-norgestrel after oral administration.

Authors:  E Weiner; A Victor; E D Johansson
Journal:  Contraception       Date:  1976-11       Impact factor: 3.375

4.  Metabolism of radioactive 17alpha-ethynylestradiol by women.

Authors:  M T Abdel-Aziz; K I Williams
Journal:  Steroids       Date:  1970-05       Impact factor: 2.668

5.  Radioactivity in the breast milk of lactating women after oral administration of 3H-norethynodrel.

Authors:  K R Laumas; P K Malkani; S Bhatnagar; V Laumas
Journal:  Am J Obstet Gynecol       Date:  1967-06-01       Impact factor: 8.661

6.  Plasma concentrations of ethinylestradiol and D-norgestrel during two immediate postabortal oral contraceptive cycles.

Authors:  P Lähteenmäki; C G Nilsson
Journal:  Contraception       Date:  1978-01       Impact factor: 3.375

7.  Studies on low-dose oral contraceptives: cervical mucus and plasma hormone changes in relation to circulating D-norgestrel and 17alpha ethynyl-estradiol concentrations.

Authors:  M Elstein; S E Morris; G V Groom; D A Jenner; J J Scarisbrick; E H Cameron
Journal:  Fertil Steril       Date:  1976-08       Impact factor: 7.329

8.  Ethynyl cleavage of 17 alpha-ethynylestradiol in the rhesus monkey.

Authors:  L A Raitano; W Slikker; D E Hill; H E Hadd; T Cairns; E D Helton
Journal:  Drug Metab Dispos       Date:  1981 Mar-Apr       Impact factor: 3.922

9.  Phenobarbitone interaction with oral contraceptive steroids in the rabbit and rat.

Authors:  D J Back; A M Breckenridge; F E Crawford; M L Orme; P H Rowe
Journal:  Br J Pharmacol       Date:  1980-07       Impact factor: 8.739

10.  Levonorgestrel in milk and plasma of breast-feeding women with a levonorgestrel-releasing IUD.

Authors:  M Heikkilä; M Haukkamaa; T Luukkainen
Journal:  Contraception       Date:  1982-01       Impact factor: 3.375
View more
  31 in total

1.  The effects of an oral contraceptive containing ethinyloestradiol and norgestrel on CYP3A activity.

Authors:  Donna J Belle; John T Callaghan; J Christopher Gorski; Juan F Maya; Omiema Mousa; Steven A Wrighton; Stephen D Hall
Journal:  Br J Clin Pharmacol       Date:  2002-01       Impact factor: 4.335

2.  Unintended pregnancies and contraceptive use.

Authors: 
Journal:  BMJ       Date:  1991-03-30

3.  Effects of cytochrome P450 inducers on 17alpha-ethinyloestradiol (EE2) conjugation by primary human hepatocytes.

Authors:  A P Li; N R Hartman; C Lu; J M Collins; J M Strong
Journal:  Br J Clin Pharmacol       Date:  1999-11       Impact factor: 4.335

Review 4.  Pharmacokinetic drug interactions involving 17alpha-ethinylestradiol: a new look at an old drug.

Authors:  Hongjian Zhang; Donghui Cui; Bonnie Wang; Yong-Hae Han; Praveen Balimane; Zheng Yang; Michael Sinz; A David Rodrigues
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

Review 5.  Clinically significant drug interactions with cyclosporin. An update.

Authors:  C Campana; M B Regazzi; I Buggia; M Molinaro
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

6.  Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteers.

Authors:  D Ouellet; A Hsu; J Qian; C S Locke; C J Eason; J H Cavanaugh; J M Leonard; G R Granneman
Journal:  Br J Clin Pharmacol       Date:  1998-08       Impact factor: 4.335

7.  Ordinal scale and statistics in medical research.

Authors:  M Forrest; B Andersen
Journal:  Br Med J (Clin Res Ed)       Date:  1986-02-22

8.  Hepatic adenomas induced by norethisterone in patients receiving renal dialysis.

Authors:  P A Kalra; J A Guthrie; J B Dibble; J H Turney; A M Brownjohn
Journal:  Br Med J (Clin Res Ed)       Date:  1987-03-28

Review 9.  Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.

Authors:  R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

10.  Transdermal dual-controlled delivery of contraceptive drugs: formulation development, in vitro and in vivo evaluations, and clinical performance.

Authors:  Y W Chien; T Y Chien; R E Bagdon; Y C Huang; R H Bierman
Journal:  Pharm Res       Date:  1989-12       Impact factor: 4.200
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.